RemeGen was cofounded in 2008 by Mr. Weidong Wang, founder of Rongchang Pharmaceuticals, a leading traditional Chinese medicine company in China, and Dr. Jianmin Fang, a Canadian-American scientist. Headquartered in the coastal city of Yantai, Shandong Province of China, RemeGen has research labs and offices throughout China and the United States. RemeGen is committed to the discovery, development and commercialization of innovative and differentiated biologic drugs of significant clinical value in the key therapeutic areas of autoimmune, oncology and ophthalmic diseases.


Our mission is to discover, develop, and deliver innovative biologic drugs for major diseases in the autoimmune, oncology and ophthalmology spaces to fulfill the unmet medical needs of patients worldwide.


We aspire to be a leader within the global biopharmaceutical industry.

RemeGen’s Scientific Advisory Board comprises of five renowned professors and key opinion leaders in our areas of therapeutic development, including Dr. Gang Pei, Dr. Jianmin Fang, Dr. Ruyi He, Dr. Marsha A. Moses and Dr. Lorne Babiuk.

查看详情

科學顧問委員會成員定期與我們會面或溝通,並向我們提供諮詢服務,包括:

  • 与我们研发计划有关的
    学术更新和技术见解
  • 与我们研发计划有关的
    学术更新和技术见解
  • 与我们研发计划有关的
    学术更新和技术见解
  • 与我们研发计划有关的
    学术更新和技术见解
  • 与我们研发计划有关的
    学术更新和技术见解
TwitterFacebook微博

Company Wechat

© All Right Reserved .  ICP:鲁ICP备11031710号-1